Directa Plus has announced an agreement with Iterchimica for the supply of its G+ ITC1 nanoplatelets for use in the asphalt and bitumen sector. Directa’s graphene is the differentiating component of the Gipave® supermodifier that has been the subject of recent trials in Italy and the UK. The agreement is for an initial duration of three years and Directa has received its first order from Iterchimica, as indicated in the 13th March trading update. We consider this a promising medium
14 Apr 2020
Agreement with Iterchimica
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Agreement with Iterchimica
Directa Plus Plc (DCTA:LON) | 19.2 0.1 3.8% | Mkt Cap: 12.7m
- Published:
14 Apr 2020 -
Author:
James Tetley -
Pages:
3
Directa Plus has announced an agreement with Iterchimica for the supply of its G+ ITC1 nanoplatelets for use in the asphalt and bitumen sector. Directa’s graphene is the differentiating component of the Gipave® supermodifier that has been the subject of recent trials in Italy and the UK. The agreement is for an initial duration of three years and Directa has received its first order from Iterchimica, as indicated in the 13th March trading update. We consider this a promising medium